Literature DB >> 1371169

Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides.

D Ou1, P Chong, B Tripet, S Gillam.   

Abstract

A nested set of 11 overlapping synthetic peptides covering the entire sequence of rubella virus capsid protein was synthesized, purified, and tested against human rubella virus-specific T-cell lines and rubella virus-seropositive sera. T-cell lines derived from four donors responded strongly to four synthetic peptides containing residues 96 to 123, 119 to 152, 205 to 233, and 255 to 280. Only one peptide (residues 255 to 280) was recognized by all four T-cell lines. Two human immunodominant linear B-cell epitopes were mapped to residues 1 to 30 and 96 to 123 by using peptide-specific enzyme-linked immunosorbent assay. All 11 synthetic peptides were highly immunogenic and induced strong antibody responses in rabbits against the respective immunized peptides. Seven of the 11 rabbit antipeptide antisera (anti-1-30, -74-100, -96-123, -119-152, -205-233, -231-257, and -255-280) specifically recognized the capsid protein on immunoblots. Identification of these T- and B-cell epitopes represents the first step toward rational design of synthetic vaccines against rubella.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371169      PMCID: PMC240908     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.

Authors:  T Vesikari; E Buimovici-Klein
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  T-cell antigenic sites tend to be amphipathic structures.

Authors:  C DeLisi; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

3.  Prediction of immunodominant helper T cell antigenic sites from the primary sequence.

Authors:  H Margalit; J L Spouge; J L Cornette; K B Cease; C Delisi; J A Berzofsky
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

4.  Immunocytochemical focus assay for potency determination of measles-mumps-rubella trivalent vaccine.

Authors:  A Fukuda; M Hishiyama; Y Umino; A Sugiura
Journal:  J Virol Methods       Date:  1987-03       Impact factor: 2.014

5.  Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.

Authors:  G H Cohen; V J Isola; J Kuhns; P W Berman; R J Eisenberg
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site.

Authors:  D R Milich; A McLachlan; G B Thornton; J L Hughes
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.

Authors:  E Celis; D Ou; L Otvos
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

8.  Rubella virus wild-type and RA27/3 strains: a comparison by polyacrylamide-gel electrophoresis and radioimmune precipitation.

Authors:  L Ho-Terry; A Cohen; P Londesborough
Journal:  J Med Microbiol       Date:  1982-08       Impact factor: 2.472

9.  Detailed immunologic analysis of the structural polypeptides of rubella virus using monoclonal antibodies.

Authors:  M N Waxham; J S Wolinsky
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

10.  HLA-DR antigens and the rubella-specific immune response in man.

Authors:  S Kato; S Muranaka; I Takakura; M Kimura; K Tsuji
Journal:  Tissue Antigens       Date:  1982-02
View more
  8 in total

1.  Identification of domains in rubella virus genomic RNA and capsid protein necessary for specific interaction.

Authors:  Z Liu; D Yang; Z Qiu; K T Lim; P Chong; S Gillam
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

2.  Expression and characterization of virus-like particles containing rubella virus structural proteins.

Authors:  Z Qiu; D Ou; T C Hobman; S Gillam
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clones.

Authors:  D Ou; P Chong; Y Choi; P McVeigh; W A Jefferies; G Koloitis; A J Tingle; S Gillam
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope.

Authors:  S Lombardi; C Garzelli; C La Rosa; L Zaccaro; S Specter; G Malvaldi; F Tozzini; F Esposito; M Bendinelli
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.

Authors:  M McCarthy; A Lovett; R H Kerman; A Overstreet; J S Wolinsky
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

6.  Characterization of the specificity and genetic restriction of human CD4+ cytotoxic T cell clones reactive to capsid antigen of rubella virus.

Authors:  D Ou; P Chong; P McVeish; W A Jefferies; S Gillam
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

Review 7.  Molecular biology of rubella virus.

Authors:  T K Frey
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

8.  Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition.

Authors:  D Ou; L A Mitchell; M Ho; D Dćarie; A J Tingle; G T Nepom; M Lacroix; M Zrein
Journal:  Hum Immunol       Date:  1994-03       Impact factor: 2.850

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.